Funding for this research was provided by:
Sanofi Genzyme (GZ-2015-11442)
Text and Data Mining valid from 2020-02-22
Received: 4 July 2019
Accepted: 10 February 2020
First Online: 22 February 2020
Ethics approval and consent to participate
: The aCQuiRE Study received multi-site ethical approval from the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (Approval number: HREC/7/QRBW/91) and subsequent governance approval at all study sites. Governance and ethical processes included approval of this protocol. All patients provide informed, written consent prior to participation in the study.
: Not applicable.
: MT has previously received fees for lectures, advisory boards and conference attendance from Sanofi-Genzyme. CD is a member of the Sanofi Genzyme Educational Advisory Board and has previously received sponsorship to attend conferences. SS has received fees from Sanofi-Genzyme for Advisory Board participation. AM is a member of the BMC Nephrology Editorial Board (Associate Editor) and has had no role in the peer review or handling of this manuscript by that journal. The other authors declare that they have no competing interests.